Five year course of tamoxifen can offer long-term benefit for women with breast cance

[News]

Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years.

More... (http://www.news-medical.net/news/20110322/Five-year-course-of-tamoxifen-can-offer-long-term-benefit-for-women-with-breast-cancer.aspx)